Acquisition of Patents and Intangibles (Tables)

12 Months Ended

May 31, 2020

Summary of the Net Purchase Price and Allocation to the Acquired Assets

A summary of the net purchase price and allocation to the acquired assets is as follows:

	Prostagene LLC
CytoDyn Inc. Equity	$	11,558,000
Acquisition Expenses		741,297
Release of Deferred Tax Asset		2,826,919
Total Cost of Acquisition	$	15,126,216
Intangible Assets	$	15,126,216
Other		—
Allocation of Acquisition Costs	$	15,126,216

Intangible Assets Activity

The following presents intangible assets activity, inclusive of patents:

	May 31, 2020			May 31, 2019
Gross carrying amounts	$	3,500,000		$	3,500,000
Intangible asset acquisition:
ProstaGene, LLC		15,126,216			15,126,216
Website development costs		19,553			19,553
Accumulated amortization		(5,189,897	)		(3,170,315	)
Total amortizable intangible assets, net		13,455,872			15,475,454
Patents currently not amortized		—			—
Carrying value of intangibles, net	$	13,455,872		$	15,475,454